Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease

被引:0
|
作者
Ishii, K
Sasaki, M
Yamaji, S
Sakamoto, S
Kitagaki, H
Mori, E
机构
[1] Hyogo Inst Aging Brain & Cognit Disorders, Div Neuroimaging Res, Himeji, Hyogo 670, Japan
[2] Hyogo Inst Aging Brain & Cognit Disorders, Div Clin Neurosci, Himeji, Hyogo 670, Japan
[3] Kobe Univ, Sch Med, Dept Radiol, Kobe, Hyogo 650, Japan
关键词
PET; Alzheimer's disease; oxygen-15-labeled water; hippocampus; cerebral blood flow;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to clarify the changes in hippocampal perfusion in mild-to-moderate Alzheimer's disease using PET and O-15-labeled water. Methods: Sixteen patients with probable mild-to-moderate Alzheimer's disease (age: 68.1 +/- 11.3 yr; MMSE: 21.1 +/- 4.5) and 10 normal volunteers (age: 65.1 +/- 8.2 yr) were studied. Regional cerebral blood flow (CBF) and cerebral blood volume (CBV) were measured using (15)0-labeled water autoradiographic method, (CO)-O-15-gas inhalation technique and PET. Results: Although the mean CBF in the parietotemporal region was significantly lower in the patient group than in the control group, the mean CBF in the hippocampus did not show significant reduction between the two groups, both in absolute and relative values. There was no significant regional CBV difference between the two groups. Parietotemporal perfusion correlated well with cognitive scores, both in absolute and relative values, in Alzheimer's disease, but hippocampal perfusion did not correlate well. Conclusion: Hippocampal perfusion was preserved in mild-to-moderate Alzheimer's disease.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [1] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [2] Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
    Imbimbo, Bruno P.
    Ottonello, Simone
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Greco, Antonio
    Seripa, Davide
    Pilotto, Alberto
    Panza, Francesco
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (02) : 135 - 149
  • [3] Optimizing diagnosis and management in mild-to-moderate Alzheimer's disease
    Galvin, James E.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (03) : 291 - 304
  • [5] Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
    Egan, Michael F.
    Kost, James
    Tariot, Pierre N.
    Aisen, Paul S.
    Cummings, Jeffrey L.
    Vellas, Bruno
    Sur, Cyrille
    Mukai, Yuki
    Voss, Tiffini
    Furtek, Christine
    Mahoney, Erin
    Mozley, Lyn Harper
    Vandenberghe, Rik
    Mo, Yi
    Michelson, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1691 - 1703
  • [6] Predictors of Patient Dependence in Mild-to-Moderate Alzheimer's Disease
    Benke, Thomas
    Sanin, Guenter
    Lechner, Anita
    Dal-Bianco, Peter
    Ransmayr, Gerhard
    Uranues, Margarete
    Marksteiner, Josef
    Gaudig, Maren
    Schmidt, Reinhold
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (02) : 443 - 449
  • [7] Dysphagia is closely related to frailty in mild-to-moderate Alzheimer's disease
    Guner, Merve
    Bas, Arzu Okyar
    Ceylan, Serdar
    Kahyaoglu, Zeynep
    Coteli, Suheyla
    Unsal, Pelin
    cavusoglu, Cagatay
    Ozsurekci, Cemile
    Dogu, Burcu Balam
    Cankurtaran, Mustafa
    Halil, Meltem Gulhan
    BMC GERIATRICS, 2023, 23 (01)
  • [8] Persistent use of Analgesic Medications in Mild-to-Moderate Alzheimer's Disease
    Gallini, Adeline
    Gardette, Virginie
    Vellas, Bruno
    Lapeyre-Mestre, Maryse
    Andrieu, Sandrine
    Brefel-Courbon, Christine
    DRUGS & AGING, 2013, 30 (06) : 439 - 445
  • [9] Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
    Seltzer, Ben
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 1 - 6
  • [10] Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
    Doody, Rachelle S.
    Thomas, Ronald G.
    Farlow, Martin
    Iwatsubo, Takeshi
    Vellas, Bruno
    Joffe, Steven
    Kieburtz, Karl
    Raman, Rema
    Sun, Xiaoying
    Aisen, Paul S.
    Siemers, Eric
    Liu-Seifert, Hong
    Mohs, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04): : 311 - 321